Slaughters, Freshfields and US duo lead on Reckitt Benckiser spin-off

pharma-drugs-pills

Slaughter and May and Freshfields Bruckhaus Deringer are among four firms to have taken roles on the demerger of Reckitt Benckiser’s pharmaceutical business.